Literature DB >> 16476058

Peritoneal macrophages suppress T-cell activation by amino acid catabolism.

R Matlack1, K Yeh, L Rosini, D Gonzalez, J Taylor, D Silberman, A Pennello, J Riggs.   

Abstract

T-lymphocyte activation triggered by anti-CD3, endogenous or exogenous superantigen, and mitogens was suppressed in a cell-dose-dependent fashion by peritoneal cavity (PerC) leucocytes. Study of lymphocyte-deficient mice and the use of multiparameter fluorescence-activated cell sorter analyses revealed that macrophages were responsible for this form of immune regulation. Interferon-gamma was essential to trigger suppression, which, by enzyme inhibition studies, was shown to be the result of tryptophan and arginine catabolism. These results illustrate that macrophages, which are classically defined by their innate effector function as antigen-presenting cells, have the potential to temper adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476058      PMCID: PMC1782234          DOI: 10.1111/j.1365-2567.2005.02312.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  50 in total

Review 1.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  Suppressor T cells--they're back and critical for regulation of autoimmunity!

Authors:  L Chatenoud; B Salomon; J A Bluestone
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism.

Authors:  O Atochina; T Daly-Engel; D Piskorska; E McGuire; D A Harn
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  M-1/M-2 macrophages and the Th1/Th2 paradigm.

Authors:  C D Mills; K Kincaid; J M Alt; M J Heilman; A M Hill
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

6.  Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.

Authors:  Toshiro Futagawa; Hisaya Akiba; Tomohiro Kodama; Kazuyoshi Takeda; Yasuyuki Hosoda; Hideo Yagita; Ko Okumura
Journal:  Int Immunol       Date:  2002-03       Impact factor: 4.823

7.  Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma.

Authors:  L S Cauley; E E Miller; M Yen; S L Swain
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

8.  Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection.

Authors:  Lea Brys; Alain Beschin; Geert Raes; Gholamreza Hassanzadeh Ghassabeh; Wim Noël; Jef Brandt; Frank Brombacher; Patrick De Baetselier
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

9.  Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells.

Authors:  R L Blumenthal; D E Campbell; P Hwang; R H DeKruyff; L R Frankel; D T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2001-02       Impact factor: 10.793

10.  B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.

Authors:  S Y Tseng; M Otsuji; K Gorski; X Huang; J E Slansky; S I Pai; A Shalabi; T Shin; D M Pardoll; H Tsuchiya
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

View more
  17 in total

Review 1.  Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppression.

Authors:  Bin Li; Mark I Greene
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

Review 2.  Macrophages in hepatitis B and hepatitis C virus infections.

Authors:  Mathis Heydtmann
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

3.  High macrophage PD-L1 expression not responsible for T cell suppression.

Authors:  Naomi Goldman; Yelizavet D Lomakova; Jennifer Londregan; Amanda Bucknum; Kelley DePierri; John Somerville; James E Riggs
Journal:  Cell Immunol       Date:  2017-12-30       Impact factor: 4.868

4.  Peritoneal T lymphocyte regulation by macrophages.

Authors:  G Composto; D Gonzalez; A Bucknum; D Silberman; J Taylor; M Kozlowski; T Bloomfield; T Bartlett; J Riggs
Journal:  Immunobiology       Date:  2010-04-10       Impact factor: 3.144

5.  Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread.

Authors:  Jennifer J Cenker; Ryan D Stultz; David McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

6.  PHA eludes macrophage suppression to activate CD8+ T cells.

Authors:  Yelizavet D Lomakova; Jennifer Londregan; Jeffrey Maslanka; Naomi Goldman; John Somerville; James E Riggs
Journal:  Immunobiology       Date:  2018-11-03       Impact factor: 3.144

7.  Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression.

Authors:  Andrew L Doedens; Christian Stockmann; Mark P Rubinstein; Debbie Liao; Na Zhang; David G DeNardo; Lisa M Coussens; Michael Karin; Ananda W Goldrath; Randall S Johnson
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

Review 8.  Challenges and future perspectives of T cell immunotherapy in cancer.

Authors:  Maria Teresa P de Aquino; Anshu Malhotra; Manoj K Mishra; Anil Shanker
Journal:  Immunol Lett       Date:  2015-06-19       Impact factor: 3.685

9.  Erythropoietin increases macrophage-mediated T cell suppression.

Authors:  Michelle A Wood; Naomi Goldman; Kelley DePierri; John Somerville; James E Riggs
Journal:  Cell Immunol       Date:  2016-05-27       Impact factor: 4.868

10.  Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates.

Authors:  Theresa L Chang; Arielle Klepper; Jian Ding; John Garber; Aprille Rapista; Arevik Mosoian; Wolfgang Hubner; Julio Gutierrez; Jose Walewski; Jeffrey Abergel; Thomas Schiano; Andrea Branch
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.